As expression levels of AR can be used to characterize different subgroups of castration-resistant bone metastases probably needing different types of treatments [41, 50], the roles of extratumoral macrophages, HO-1, iron metabolism, and coagulation in prostate cancer bone metastases should be explored in more detail. The gene discussed is HMOX1; the disease is prostate carcinoma.